address1,city,zip,country,phone,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,dividendRate,dividendYield,exDividendDate,payoutRatio,beta,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,lastDividendValue,lastDividendDate,quoteType,currentPrice,recommendationKey,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,marketState,corporateActions,regularMarketTime,exchange,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,longName,hasPrePostMarketData,firstTradeDateMilliseconds,cryptoTradeable,regularMarketChangePercent,regularMarketPrice,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,epsTrailingTwelveMonths,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,trailingPegRatio
Agavagen 52A,Lidingö,181 55,Sweden,46 8 35 73 55,https://www.combigene.com,Biotechnology,biotechnology,Biotechnology,Healthcare,healthcare,Healthcare,"CombiGene AB (publ) engages in the development of gene therapy for severe life-altering diseases in Sweden. The company is developing two candidates for severe chronic pain conditions, which are in preclinical studies include COZY01, a peptide treatment; and COZY02, a gene therapy treatment. It is also developing CG01, an adeno-associated virus-based gene therapy targeting epileptic seizures. The company has a collaboration agreement with Danish company Zyneyro to develop a treatment for chronic pain conditions. CombiGene AB (publ) was incorporated in 1990 and is based in Lidingö, Sweden.",9,"[{'maxAge': 1, 'name': 'Mr. Peter  Ekolind', 'age': 60, 'title': 'Chief Executive Officer', 'yearBorn': 1964, 'fiscalYear': 2023, 'totalPay': 893492, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Annika  Ericson', 'title': 'Chief Scientific Officer', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}]",1703980800,[],86400,4,2.4,2.4,2.35,2.45,2.4,2.4,2.35,2.45,0.2,8.06,1749772800,0.0,1.219,87330,87330,51233,76232,76232,2.35,2.4,49589040,2.1,2.6,24.804604,2.425,2.425,0.2,0.08333333,SEK,False,-24640976,0.0,16460537,19801200,0.37338,0.04063,20662100,3.615,0.66390043,1735603200,1767139200,1735603200,-44877832,-2.18,-12.325,0.767,-0.066147864,0.11844492,0.2,1749772800,EQUITY,2.4,none,73747944,3.724,-32124192,0,17.354,17.471,1999187,0.101,-0.24122,-0.47733003,-17568098,-17331912,-29949218,-0.778,0.0,0.0,-22.06276,SEK,LARK.ST,en-US,US,Equity,Delayed Quote,True,HIGH,PREPRE,[],1752161023,STO,finmb_272213430,Europe/Stockholm,CEST,7200000,se_market,False,Lärkberget AB (publ),False,1750230000000,False,0.0,2.4,0.0,2.35 - 2.45,Stockholm,51233,0.3000002,0.14285724,2.1 - 2.6,-0.19999981,-0.076923005,-6.614786,-2.18,-0.024999857,-0.010309219,-0.024999857,-0.010309219,15,0,
